Dishonesty in medical research and publication and the remedial measures.
作者信息
Neema Praveen Kumar
机构信息
Department of Anaesthesiology and Critical Care, All Institute of Medical Sciences, Raipur, Chhattisgarh, India.
出版信息
Ann Card Anaesth. 2018 Apr-Jun;21(2):111-113. doi: 10.4103/aca.ACA_58_18.
Abstract
摘要
相似文献
1
Dishonesty in medical research and publication and the remedial measures.医学研究与发表中的不诚实行为及补救措施。
Ann Card Anaesth. 2018 Apr-Jun;21(2):111-113. doi: 10.4103/aca.ACA_58_18.
2
Retraction policies of top scientific journals ranked by impact factor.按影响因子排名的顶级科学期刊的撤稿政策。
J Med Libr Assoc. 2015 Jul;103(3):136-9. doi: 10.3163/1536-5050.103.3.006.
3
Standards for ethical publication.伦理出版标准。
Am J Otolaryngol. 2007 Jan-Feb;28(1):1-2. doi: 10.1016/j.amjoto.2006.11.002.
4
Figure errors, sloppy science, and fraud: keeping eyes on your data.图表错误、草率的科学和欺诈：密切关注您的数据。
J Clin Invest. 2019 Mar 25;129(5):1805-1807. doi: 10.1172/JCI128380.
5
How can the scientific community ensure the integrity of COVID-19 research?科学界如何确保新冠病毒研究的诚信性？
CMAJ. 2020 Jul 13;192(28):E817-E818. doi: 10.1503/cmaj.1095881.
6
Publication ethics policies for medical journals.医学期刊的出版伦理政策。
Indian J Med Ethics. 2004 Jul-Sep;1(3):93.
7
Medical journals and medical reporting.医学期刊与医学报道。
N Engl J Med. 2000 Jun 1;342(22):1668-71. doi: 10.1056/NEJM200006013422212.
8
Trends in scientific publishing: Dark clouds loom large.科学出版趋势：乌云密布。
J Neurol Sci. 2016 Apr 15;363:119-20. doi: 10.1016/j.jns.2016.02.040. Epub 2016 Feb 17.
9
Fake! Part II: By Caveman.假的！第二部分：作者：穴居人
J Cell Sci. 2006 Dec 15;119(Pt 24):5007-9.
10
The importance of being earnest in post-publication review: scientific fraud and the scourges of anonymity and excuses.发表后审查中秉持严谨态度的重要性：科学欺诈以及匿名和借口的危害。
Oncogene. 2018 Feb 8;37(6):695-696. doi: 10.1038/onc.2017.390. Epub 2017 Oct 16.
引用本文的文献
1
Guidelines for Editing Biomedical Journals: Recommended by Academy of Medical Sciences of Bosnia and Herzegovina.《生物医学期刊编辑指南：波斯尼亚和黑塞哥维那医学科学院推荐》
Acta Inform Med. 2020 Dec;28(4):232-236. doi: 10.5455/aim.2020.28.232-236.
2
A review of the current concerns about misconduct in medical sciences publications and the consequences.当前对医学科学出版物不当行为及其后果的关注综述。
Daru. 2020 Jun;28(1):359-369. doi: 10.1007/s40199-020-00332-1. Epub 2020 Feb 19.
本文引用的文献
1
Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review.老年人中低密度脂蛋白胆固醇与死亡率之间缺乏关联或呈负相关：一项系统综述。
BMJ Open. 2016 Jun 12;6(6):e010401. doi: 10.1136/bmjopen-2015-010401.
2
The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective.弗雷明汉心脏研究与心血管疾病的流行病学：历史视角。
Lancet. 2014 Mar 15;383(9921):999-1008. doi: 10.1016/S0140-6736(13)61752-3. Epub 2013 Sep 29.
3
Misconduct accounts for the majority of retracted scientific publications.不当行为导致了大多数被撤回的科学出版物。
Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):17028-33. doi: 10.1073/pnas.1212247109. Epub 2012 Oct 1.
4
GlaxoSmithKline pays $3bn to settle dispute over rosiglitazone and other drugs.葛兰素史克支付30亿美元解决关于罗格列酮及其他药物的争端。
BMJ. 2011 Nov 7;343:d7234. doi: 10.1136/bmj.d7234.
5
Medical research: Is everything all right?医学研究：一切都还好吗？
J Anaesthesiol Clin Pharmacol. 2011 Apr;27(2):159-61. doi: 10.4103/0970-9185.81818.
6
Statins for the primary prevention of cardiovascular disease.他汀类药物用于心血管疾病的一级预防。
Cochrane Database Syst Rev. 2011 Jan 19(1):CD004816. doi: 10.1002/14651858.CD004816.pub4.
7
How the case against the MMR vaccine was fixed.反对麻腮风三联疫苗的诉讼是如何被操纵的。
BMJ. 2011 Jan 5;342:c5347. doi: 10.1136/bmj.c5347.
8
COPE's retraction guidelines.COPE的撤稿指南。
Lancet. 2009 Dec 5;374(9705):1876-7. doi: 10.1016/S0140-6736(09)62074-2.
9
When four plus four is less than eight: the Nuss operation.
Eur J Cardiothorac Surg. 2009 Apr;35(4):559-60. doi: 10.1016/j.ejcts.2008.12.003.
10
Surgeons produce innovative ideas which are frequently lost in the labyrinth of patents.
Eur J Cardiothorac Surg. 2009 Mar;35(3):480-8. doi: 10.1016/j.ejcts.2008.11.025. Epub 2009 Jan 24.
Zotero 插件